journal article·2025-02Open access

Photochemical Stabilization of Self‐Assembled Spherical Nucleic Acids

Sepideh Kaviani, Haochen Bai, Trishalina Das, Jathavan Asohan, Abdelrahman Elmanzalawy, Julian Marlyn, Lea El Choueiri, Masad J. Damha, Quentin Laurent, Hanadi F. Sleiman

Small· Volume 21· Issue 7

Abstract

Abstract Oligonucleotide therapeutics, including antisense oligonucleotides and small interfering RNA, offer promising avenues for modulating the expression of disease‐associated proteins. However, challenges such as nuclease degradation, poor cellular uptake, and unspecific targeting hinder their application. To overcome these obstacles, spherical nucleic acids have emerged as versatile tools for nucleic acid delivery in biomedical applications. Our laboratory has introduced sequence‐defined DNA amphiphiles which self‐assemble in aqueous solutions. Despite their advantages, self‐assembled SNAs can be inherently fragile due to their reliance on non‐covalent interactions and fall apart in biologically relevant conditions, specifically by interaction with serum proteins. Herein, this challenge is addressed by introducing two methods of covalent crosslinking of SNAs via UV irradiation. Thymine photodimerization or disulfide crosslinking at the micellar interface enhance SNA stability against human serum albumin binding. This enhanced stability, particularly for disulfide crosslinked SNAs, leads to increased cellular uptake. Furthermore, this crosslinking results in sustained activity and accessibility for release of the therapeutic nucleic acid, along with improvement in unaided gene silencing. The findings demonstrate the efficient stabilization of SNAs through UV crosslinking, influencing their cellular uptake, therapeutic release, and ultimately, gene silencing activity. These studies offer promising avenues for further optimization and exploration of pre‐clinical, in vivo studies.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Advanced biosensing and bioanalysis techniques · RNA Interference and Gene Delivery · DNA and Nucleic Acid Chemistry

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Chemistry McGill University 801, Sherbrooke St. West Montreal QC H3A 0B8 Canada

University Grenoble Alpes, DCM UMR 5250 Grenoble Cedex 9 38058 France

Funding

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung · Canada Foundation for Innovation · Natural Sciences and Engineering Research Council of Canada · Fonds de recherche du Québec – Nature et technologies

References (100+)

Show source-provided references
1. 10.3390/pharmaceutics1504113010.3390/pharmaceutics15041130 ↗
2. 10.1021/acsnano.1c0509910.1021/acsnano.1c05099 ↗
3. 10.15252/emmm.20201324310.15252/emmm.202013243 ↗
4. 10.1186/s40824-022-00292-410.1186/s40824-022-00292-4 ↗
5. 10.1016/j.addr.2020.06.00210.1016/j.addr.2020.06.002 ↗
6. 10.1021/cr500679310.1021/cr5006793 ↗
7. 10.1021/ja209351u10.1021/ja209351u ↗
8. 10.1007/s40259-018-0290-510.1007/s40259-018-0290-5 ↗
9. 10.1373/clinchem.2016.26851610.1373/clinchem.2016.268516 ↗
10. 10.1016/j.molmed.2019.08.01210.1016/j.molmed.2019.08.012 ↗
11. 10.3390/cancers1407161510.3390/cancers14071615 ↗
12. 10.1002/smll.20160384710.1002/smll.201603847 ↗
13. 10.1021/acs.bioconjchem.6b0048310.1021/acs.bioconjchem.6b00483 ↗
14. 10.1021/acs.nanolett.1c0197310.1021/acs.nanolett.1c01973 ↗
15. 10.1002/agt2.12010.1002/agt2.120 ↗
16. 10.1002/smll.20231002610.1002/smll.202310026 ↗
17. 10.1016/j.biomaterials.2013.07.01910.1016/j.biomaterials.2013.07.019 ↗
18. 10.1002/anie.20231576810.1002/anie.202315768 ↗
19. 10.1089/nat.2022.006210.1089/nat.2022.0062 ↗
20. 10.1007/978-1-0716-0138-9_810.1007/978-1-0716-0138-9_8 ↗
21. 10.1002/anie.20131093710.1002/anie.201310937 ↗
22. 10.1021/acsnano.3c0594010.1021/acsnano.3c05940 ↗
23. 10.1039/C7SC01619K10.1039/C7SC01619K ↗
24. 10.1021/acsami.8b1879010.1021/acsami.8b18790 ↗
25. 10.1186/s12951-024-02648-510.1186/s12951-024-02648-5 ↗
26. 10.1093/nar/gkp84110.1093/nar/gkp841 ↗
27. Choi C. H. J. · 2020 · 475
28. 10.1021/bc100242310.1021/bc1002423 ↗
29. 10.1021/mp900172m10.1021/mp900172m ↗
30. 10.1073/pnas.111842510910.1073/pnas.1118425109 ↗
31. 10.1073/pnas.140943111110.1073/pnas.1409431111 ↗
32. 10.1021/ja808719p10.1021/ja808719p ↗
33. 10.1126/science.112555910.1126/science.1125559 ↗
34. 10.1021/nl802958f10.1021/nl802958f ↗
35. 10.1007/978-3-319-16555-410.1007/978-3-319-16555-4 ↗
36. 10.1039/b815918a10.1039/b815918a ↗
37. 10.1016/j.nantod.2015.01.00510.1016/j.nantod.2015.01.005 ↗
38. 10.1016/j.nantod.2012.01.00210.1016/j.nantod.2012.01.002 ↗
39. 10.1039/C9NR05143K10.1039/C9NR05143K ↗
40. 10.1002/adma.20080245310.1002/adma.200802453 ↗
41. 10.1021/acs.chemrev.7b0012310.1021/acs.chemrev.7b00123 ↗
42. 10.1039/D0PY00987C10.1039/D0PY00987C ↗
43. 10.1039/D1RA00079A10.1039/D1RA00079A ↗
44. 10.1016/j.biomaterials.2011.05.05010.1016/j.biomaterials.2011.05.050 ↗
45. 10.1021/acs.molpharmaceut.8b0058510.1021/acs.molpharmaceut.8b00585 ↗
46. 10.1038/sj.gt.330144610.1038/sj.gt.3301446 ↗
47. 10.1016/j.biomaterials.2014.05.04110.1016/j.biomaterials.2014.05.041 ↗
48. 10.1021/bm301095a10.1021/bm301095a ↗
49. 10.1021/bm800985e10.1021/bm800985e ↗
50. 10.1021/ja016440n10.1021/ja016440n ↗
51. 10.1021/mp800070s10.1021/mp800070s ↗
52. 10.1021/jacs.5b0894810.1021/jacs.5b08948 ↗
53. 10.1021/jacs.1c1035910.1021/jacs.1c10359 ↗
54. 10.1021/jacs.7b0003910.1021/jacs.7b00039 ↗
55. 10.1002/macp.20210044510.1002/macp.202100445 ↗
56. 10.1126/sciadv.aau115710.1126/sciadv.aau1157 ↗
57. 10.1021/jacs.2c0880810.1021/jacs.2c08808 ↗
58. 10.1038/s41467-023-36601-110.1038/s41467-023-36601-1 ↗
59. 10.1016/j.xcrp.2022.10123710.1016/j.xcrp.2022.101237 ↗
60. 10.1021/acsnano.9b0102510.1021/acsnano.9b01025 ↗
61. 10.1186/1471-2407-5-13510.1186/1471-2407-5-135 ↗
62. 10.1021/ar00039a00310.1021/ar00039a003 ↗
63. 10.1021/acs.bioconjchem.9b0030610.1021/acs.bioconjchem.9b00306 ↗
64. 10.1021/bc00003a00110.1021/bc00003a001 ↗
65. 10.3390/molecules2611310010.3390/molecules26113100 ↗
66. 10.1039/D4MR00009A10.1039/D4MR00009A ↗
67. Gilbert H. F. · Adv. Enzymol. Relat. Areas Mol. Biol. · 1993 · 63 · 69
68. 10.1016/S0169-409X(02)00179-510.1016/S0169-409X(02)00179-5 ↗
69. 10.1016/j.chembiol.2012.07.01110.1016/j.chembiol.2012.07.011 ↗
70. 10.1039/D0SC06645A10.1039/D0SC06645A ↗
71. 10.1021/bi011507510.1021/bi0115075 ↗
72. 10.1016/S0960-894X(02)00439-010.1016/S0960-894X(02)00439-0 ↗
73. 10.1038/mtna.2012.3510.1038/mtna.2012.35 ↗
74. 10.1073/pnas.180183611510.1073/pnas.1801836115 ↗
75. 10.1039/D2CC06013B10.1039/D2CC06013B ↗
76. 10.1039/D0SC00333F10.1039/D0SC00333F ↗
77. 10.1039/D3SC01591B10.1039/D3SC01591B ↗
78. 10.1039/c0cs00195c10.1039/c0cs00195c ↗
79. 10.1002/mabi.20150036310.1002/mabi.201500363 ↗
80. 10.1021/mp200379710.1021/mp2003797 ↗
81. 10.1016/j.bmc.2013.10.05710.1016/j.bmc.2013.10.057 ↗
82. 10.1002/jms.154410.1002/jms.1544 ↗
83. Mander L. · 2010
84. Matsugo S. · Biochem. Mol. Biol. Int. · 1996 · 38 · 51
85. 10.1039/B916128G10.1039/B916128G ↗
86. 10.1021/acs.macromol.0c0060410.1021/acs.macromol.0c00604 ↗
87. 10.1039/C5PY01925G10.1039/C5PY01925G ↗
88. 10.1016/S1011-1344(01)00206-810.1016/S1011-1344(01)00206-8 ↗
89. 10.1016/j.mrfmmm.2004.09.01210.1016/j.mrfmmm.2004.09.012 ↗
90. 10.1093/nar/gky126010.1093/nar/gky1260 ↗
91. 10.1021/acscentsci.9b0017410.1021/acscentsci.9b00174 ↗
92. 10.1002/smll.20150002710.1002/smll.201500027 ↗
93. 10.1021/acs.molpharmaceut.0c0056210.1021/acs.molpharmaceut.0c00562 ↗
94. 10.1039/D0SC05447J10.1039/D0SC05447J ↗
95. Luo Y. · Sep. Sci. Technol. · 2011 · 10 · 283
96. 10.1021/jacsau.1c0012810.1021/jacsau.1c00128 ↗
97. 10.1002/anie.20210732710.1002/anie.202107327 ↗
98. 10.1021/acsnano.3c0460810.1021/acsnano.3c04608 ↗
99. 10.1189/jlb.70.1.14210.1189/jlb.70.1.142 ↗
100. 10.1096/fj.07-8348com10.1096/fj.07-8348com ↗